Alexy Inciarte

Villarroel Street 170
Barcelona, CT 08036, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 70 publications

Community-Associated Methicillin-Resistant Staphylococcus aureus Among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV Who Engage in Chemsex in Barcelona, Spain: Epidemiological Patterns and Implications for Infection Control.

Community-Associated Methicillin-Resistant Staphylococcus aureus Among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV Who Engage in Chemsex in Barcelona, Spain: Epidemiological Patterns and Implications for Infection Control.

Journal: Microorganisms

Published: July 02, 2026

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study.

Switching from etravirine to doravirine in people with HIV harbouring NNRTI resistance-associated mutations: the DorSwitch pilot study.

Journal: The Journal of antimicrobial chemotherapy

Published: May 15, 2026

HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort.

HBV Serological Profiles and Vaccination Status in People with HIV in the Transition to a Tenofovir-Sparing Era: Insights from a Large HIV Cohort.

Journal: Infectious diseases and therapy

Published: April 09, 2026

Retention in HIV care and immunovirological outcomes among migrants and non-migrants: A 24-year cohort study in Barcelona.

Retention in HIV care and immunovirological outcomes among migrants and non-migrants: A 24-year cohort study in Barcelona.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 28, 2026

Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study.

Effectiveness, Sex Differences, and Patient Experience in Real-World Use of Long-Acting Cabotegravir and Rilpivirine: Results from a Prospective Study.

Journal: Infectious diseases and therapy

Published: March 25, 2026

Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.

Annual vs semi-annual follow-up in low complexity virologically suppressed people with HIV: a randomized interventional trial.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: March 06, 2026

Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study.

Baseline resistance mutations and virological response to dolutegravir in treatment-naïve patients: a multicentre NGS study.

Journal: The Journal of antimicrobial chemotherapy

Published: November 14, 2025

Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024).

Incidence, Clinical Features and Vaccination Coverage of Pneumococcal Disease in People Living with HIV: A Retrospective Cohort Study (2015-2024).

Journal: Vaccines

Published: October 31, 2025

Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension study.

Short-cycle three-day-per-week efavirenz/emtricitabine/tenofovir disoproxil fumarate therapy: a seven-year extension study.

Journal: The Journal of antimicrobial chemotherapy

Published: October 27, 2025

Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.

Hepatitis B Outcomes After Switching to Long-Acting Cabotegravir/Rilpivirine in People With HIV: Reactivation, Incident Infection, and Liver Safety Across Diverse Serological Profiles.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: October 14, 2025

Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.

Immune reconstitution in very advanced HIV patients treated with dolutegravir vs. darunavir-based triple antiretroviral therapy: the Advanz-4 randomized clinical trial.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: August 16, 2025

The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?

The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?

Journal: Infectious diseases and therapy

Published: July 21, 2025

Showing 1-12 of 70

Last Updated: 09/26/2026